Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-09 Slack David W. President & CBO Shares withheld for taxes −3,358 $3.00 $10K 20,642
2023-01-09 Slack David W. President & CBO Grant or award · Stock Options (Right to Buy) +12,000 12,000
2023-01-09 Buck Kristen K EVP, R&D and CMO Grant or award +18,000 38,482
2023-01-09 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −2,147 $3.00 $6K 36,335
2023-01-09 Buck Kristen K EVP, R&D and CMO Grant or award · Stock Options (Right to Buy) +9,000 9,000
2023-01-09 Flowers Cynthia Louise Director Grant or award +20,000 29,721
2023-01-09 BROWN GREGORY B Director Grant or award +20,000 29,934
2023-01-09 Ruoslahti Erkki Director Grant or award +20,000 20,000
2023-01-09 Mazzo David J Chief Executive Officer Grant or award +60,000 109,285
2023-01-09 Mazzo David J Chief Executive Officer Shares withheld for taxes −7,845 $3.00 $24K 101,440
2023-01-09 Mazzo David J Chief Executive Officer Grant or award · Stock Options (Right to Buy) +30,000 30,000
2023-01-09 AZAB MOHAMMAD Director Grant or award +20,000 39,200
2023-01-09 HENSON HEIDI Director Grant or award +20,000 20,000
2023-01-09 KLOSK STEVEN M Director Grant or award +20,000 30,090
2022-09-15 AZAB MOHAMMAD Director Grant or award +19,200 $6.25 $120K 19,200
2022-09-01 Buck Kristen K EVP, R&D and CMO Grant or award +58,000 $0.50 $29K 377,203
2022-09-01 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −25,183 $0.50 $13K 352,020
2022-09-01 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −44,776 $0.50 $22K 307,244
2022-09-01 Mazzo David J Chief Executive Officer Grant or award +150,000 $0.50 $75K 809,186
2022-09-01 Mazzo David J Chief Executive Officer Shares withheld for taxes −69,742 $0.50 $35K 739,444

Page 5 of 18 · 345 trades